لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Tristan Born, Marion Aruanno, Eleftheria Kampouri, Matteo Mombelli, Pierre Monney, Piergiorgio Tozzi, Frederic Lamoth

المصدر: Mycopathologia, vol. 187, no. 2-3, pp. 249-258

مصطلحات موضوعية: Adult, Antifungal Agents, Endocarditis, Veterinary (miscellaneous), Microbial Sensitivity Tests, Amphotericin B/pharmacology, Amphotericin B/therapeutic use, Antifungal Agents/pharmacology, Antifungal Agents/therapeutic use, Aspergillosis/diagnosis, Aspergillosis/drug therapy, Aspergillosis/microbiology, Aspergillus, Echinocandins/pharmacology, Echinocandins/therapeutic use, Endocarditis/diagnosis, Endocarditis/drug therapy, Female, Humans, Voriconazole/pharmacology, Voriconazole/therapeutic use, Aortitis, Aspergillus niger, Fungal biofilm, Invasive aspergillosis, Section Nigri, Applied Microbiology and Biotechnology, Microbiology, Echinocandins, Amphotericin B, Aspergillosis, Voriconazole, Agronomy and Crop Science

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47e183b7920aa7d77604ffc3858fd66b
https://doi.org/10.1007/s11046-022-00621-0

المؤلفون: Aragão, Ricardo Evangelista Marrocos de, Barreira, Ieda Maria Alexandre, Oliveira Neto, Francisco Holanda, Beserra, Felipe de Freitas, Araujo, Cesar Pereira de, Nascimento, Carine Soares Ramos do

المصدر: Revista Brasileira de Oftalmologia. June 2016 75(3)

مصطلحات موضوعية: Amphotericin B/therapeutic use, Candida, Endophthalmitis, Pancreatitis, Uveitis

وصف الملف: text/html

URL الوصول: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0034-72802016000300228

المؤلفون: Yanny Y. Y. Cheng, Paul E. Verweij, Jairo Gooskens, Jos Houbraken, Sjoerd G. van Duinen, Nam N Cheung

المساهمون: Westerdijk Fungal Biodiversity Institute - Food and Indoor Mycology, Westerdijk Fungal Biodiversity Institute

المصدر: The Lancet Infectious Diseases, 20(9), 1100-1100. ELSEVIER SCI LTD
The Lancet Infectious Diseases, 20(9). Lancet Publishing Group
Lancet Infectious Diseases, 20, 1100
Lancet Infectious Diseases, 20, 9, pp. 1100

مصطلحات موضوعية: medicine.medical_specialty, Eye Infections, Fungal/microbiology, Antifungal Agents, Contact Lenses, Eye Infections, lnfectious Diseases and Global Health Radboud Institute for Molecular Life Sciences [Radboudumc 4], Amphotericin B/therapeutic use, Voriconazole/therapeutic use, Young Adult, Amphotericin B, Ophthalmology, medicine, Humans, Fungal keratitis, Keratitis, Contact Lenses, Extended-Wear/adverse effects, business.industry, Extended-Wear/adverse effects, Fungal/microbiology, medicine.disease, Keratitis/microbiology, Contact lens, Infectious Diseases, Contact Lenses, Extended-Wear, Antifungal Agents/therapeutic use, Female, Voriconazole, business, Eye Infections, Fungal

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::789c6ddefa838471197b9d54cd1eb96f
https://hdl.handle.net/1887/3182868

المؤلفون: Cornu, M. (Marjorie), Bruno, B. (Benedicte), Loridant, S. (Severine), Navarin, P. (Pauline), Francois, N. (Nadine), Lanternier, F. (Fanny), Amzallag-Bellenger, E. (Elisa), Dubos, F. (Francois), Mazingue, F. (Francoise), Sendid, B. (Boualem)

المساهمون: Lille Inflammation Research International Center - U 995 (LIRIC), Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lille-Institut Pasteur de Lille, Réseau International des Instituts Pasteur (RIIP)-Réseau International des Instituts Pasteur (RIIP), Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), Mycologie moléculaire - Molecular Mycology, Institut Pasteur [Paris]-Centre National de la Recherche Scientifique (CNRS), Centre National de Référence Mycoses Invasives et Antifongiques - National Reference Center Invasive Mycoses & Antifungals (CNRMA), Institut Pasteur [Paris], Evaluation des technologies de santé et des pratiques médicales - ULR 2694 (METRICS), Université de Lille-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), This work was supported by internal funding 'Fonds d’aide à l’émergence et à l’excellence du CHRU de Lille-Bonus H'., Institut Pasteur de Lille, Réseau International des Instituts Pasteur (RIIP)-Réseau International des Instituts Pasteur (RIIP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lille-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), Institut Pasteur [Paris] (IP)-Centre National de la Recherche Scientifique (CNRS), Institut Pasteur [Paris] (IP), Lille Inflammation Research International Center (LIRIC), Centre d'infectiologie Necker-Pasteur [CHU Necker], CHU Necker - Enfants Malades [AP-HP], Santé publique : épidémiologie et qualité des soins-EA 2694 (CERIM), Université de Lille, LillOA, CHU Lille, Inserm, Université de Lille, Lille Inflammation Research International Center - U 995 [LIRIC], Lille Inflammation Research International Center (LIRIC) - U995, Centre Hospitalier Régional Universitaire [Lille] [CHRU Lille], METRICS : Evaluation des technologies de santé et des pratiques médicales - ULR 2694, Evaluation des technologies de santé et des pratiques médicales - ULR 2694 [METRICS]

المصدر: BMC Pharmacology and Toxicology
BMC Pharmacology and Toxicology, BioMed Central, 2018, 19, pp.81. ⟨10.1186/s40360-018-0273-7⟩
BMC Pharmacology and Toxicology, 2018, 19, pp.81. ⟨10.1186/s40360-018-0273-7⟩
BMC Pharmacology & Toxicology
BMC Pharmacology and Toxicology, Vol 19, Iss 1, Pp 1-5 (2018)

مصطلحات موضوعية: MESH: Leukemia, B-Cell/drug therapy, Antifungal Agents, Pyridines, Case Report, Isavuconazole, Mucormycosis, Paediatrics, Drug-monitoring, Lichtheimia, MESH: Mucormycosis/drug therapy, [SDV.MHEP.PED] Life Sciences [q-bio]/Human health and pathology/Pediatrics, lcsh:RA1190-1270, [SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases, Amphotericin B, Nitriles, Leukemia, B-Cell, MESH: Pyridines/therapeutic use, Humans, MESH: Nitriles/therapeutic use, lcsh:Toxicology. Poisons, MESH: Treatment Outcome, [SDV.MHEP.PED]Life Sciences [q-bio]/Human health and pathology/Pediatrics, MESH: Humans, lcsh:RM1-950, MESH: Child, Preschool, Triazoles, MESH: Amphotericin B/therapeutic use, MESH: Drug Therapy, Combination, lcsh:Therapeutics. Pharmacology, Treatment Outcome, MESH: Antifungal Agents/therapeutic use, [SDV.SP.PHARMA] Life Sciences [q-bio]/Pharmaceutical sciences/Pharmacology, Child, Preschool, Acute Disease, [SDV.MHEP.MI] Life Sciences [q-bio]/Human health and pathology/Infectious diseases, MESH: Triazoles/therapeutic use, [SDV.SP.PHARMA]Life Sciences [q-bio]/Pharmaceutical sciences/Pharmacology, MESH: Acute Disease, Drug Therapy, Combination, Female, MESH: Female

وصف الملف: application/pdf; application/octet-stream; application/rdf+xml; charset=utf-8

URL الوصول: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::a5df56e3e658199eb6c2d370927882d4
https://hal.univ-lille.fr/hal-02513581/document

المؤلفون: Dimopoulos, George, Frantzeskaki, Frantzeska, Kosmopoulos, Marinos, Taccone, Fabio Sylvio, Van den Abeele, Anne-Marie, Bulpa, Pierre, Forêt, Frederic, Vogelaers, Dirk, Blot, Stijn, AspICU investigators, Spapen, Herbert

المساهمون: Supporting clinical sciences, Internal Medicine Specializations

مصطلحات موضوعية: Male, Myocardium/pathology, Antifungal Agents, Voriconazole/therapeutic use, Autopsy, Aspergillosis, Pericardium/microbiology, chemistry.chemical_compound, Echinocandins, 0302 clinical medicine, Caspofungin, Pericardium, risk factors, 030212 general & internal medicine, Immunocompromised host, Lipopeptides/therapeutic use, General Medicine, Middle Aged, Infectious Diseases, medicine.anatomical_structure, 030220 oncology & carcinogenesis, Antifungal Agents/therapeutic use, Female, Immunocompetence, medicine.drug, medicine.medical_specialty, Heart Diseases, Itraconazole, Invasive Fungal Infections/drug therapy, Amphotericin B/therapeutic use, Context (language use), Dermatology, 03 medical and health sciences, Lipopeptides, Amphotericin B, medicine, critical illness, Humans, Heart Diseases/drug therapy, Voriconazole, business.industry, Myocardium, Echinocandins/therapeutic use, medicine.disease, Surgery, chemistry, incidence, Complication, business, Invasive Fungal Infections

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1561776fbf97f0bf061f87221be3939d
https://biblio.vub.ac.be/vubir/endomyocardial-and-pericardial-aspergillosis-in-critically-ill-patients(744832ed-1d53-46de-b688-dc6ad1be7252).html

المؤلفون: Monica A. Slavin, Johan Maertens, Thomas F. Patterson, O. Marchetti, Haran T. Schlamm, J. Peter Donnelly, Elizabeth M. Johnson, Peter G. Pappas, Raoul Herbrecht

المصدر: Clinical Infectious Diseases, 60, 713-20
Clinical Infectious Diseases, 60, 5, pp. 713-20
Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, vol. 60, no. 5, pp. 713-720

مصطلحات موضوعية: Microbiology (medical), Adult, Male, medicine.medical_specialty, Antifungal Agents, Adolescent, Neutropenia, Aspergillosis, Aged, Amphotericin B/therapeutic use, Antifungal Agents/therapeutic use, Child, Female, Humans, Invasive Pulmonary Aspergillosis/drug therapy, Middle Aged, Prospective Studies, Survival Analysis, Treatment Outcome, Voriconazole/therapeutic use, Young Adult, law.invention, Galactomannan, chemistry.chemical_compound, Randomized controlled trial, law, Amphotericin B, Internal medicine, medicine, Prospective cohort study, Voriconazole, Invasive Pulmonary Aspergillosis, business.industry, medicine.disease, humanities, Surgery, Infectious Diseases, chemistry, Caspofungin, business, Inflammatory diseases Radboud Institute for Molecular Life Sciences [Radboudumc 5], medicine.drug

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fee75f7c8d9efff4e7e6918bf5a35668
https://doi.org/10.1093/cid/ciu911

المؤلفون: Paiva, J. A., Mergulhao, P., Gomes, A., Taccone, F. S., Van den Abeele, A.-M., Bulpa, P., Misset, Benoît, Meersseman, W., Dimopoulos, G., Rello, J., Vogelaers, D., Blot, S.

المصدر: International Journal of Antimicrobial Agents, 50 (4), 529-535 (2017)

مصطلحات موضوعية: Aged, Amphotericin B/therapeutic use, Antifungal Agents/therapeutic use, Aspergillus/drug effects/isolation & purification, Clinical Decision-Making, Critical Illness, Delayed Diagnosis/mortality, Drug Therapy, Combination, Echinocandins/therapeutic use, Female, Fungal Proteins/therapeutic use, Humans, Intensive Care Units, Invasive Pulmonary Aspergillosis/diagnosis/drug therapy/microbiology/mortality, Male, Middle Aged, Prognosis, Respiratory System/microbiology, Treatment Outcome, Voriconazole/therapeutic use, Delayed diagnosis, Invasive pulmonary aspergillosis, Therapy, Human health sciences, Anesthesia & intensive care, Sciences de la santé humaine, Anesthésie & soins intensifs

Relation: urn:issn:0924-8579; urn:issn:1872-7913

URL الوصول: https://orbi.uliege.be/handle/2268/245127

المؤلفون: Pierre Delobel, Guillaume Martin-Blondel, Camille Laurent, Bruno Marchou, Judith Fillaux, Pierre Brousset, Paul Hofman, Antoine Berry, Quentin Hurlot

المساهمون: Pagès, Nathalie, Institut Universitaire du Cancer de Toulouse - Oncopole (IUCT Oncopole - UMR 1037), Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Centre Hospitalier Universitaire de Toulouse (CHU Toulouse)-Institut National de la Santé et de la Recherche Médicale (INSERM), Pharmacochimie et Biologie pour le Développement (PHARMA-DEV), Institut de Recherche pour le Développement (IRD)-Institut de Chimie de Toulouse (ICT-FR 2599), Institut de Recherche pour le Développement (IRD)-Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Institut de Chimie du CNRS (INC)-Centre National de la Recherche Scientifique (CNRS)-Institut National Polytechnique (Toulouse) (Toulouse INP), Université Fédérale Toulouse Midi-Pyrénées-Institut de Recherche pour le Développement (IRD)-Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées, Service de Parasitologie et Mycologie [CHU Toulouse], Institut Fédératif de Biologie (IFB), Centre Hospitalier Universitaire de Toulouse (CHU Toulouse)-Centre Hospitalier Universitaire de Toulouse (CHU Toulouse)-Pôle Biologie [CHU Toulouse], Centre Hospitalier Universitaire de Toulouse (CHU Toulouse), Centre de Physiopathologie de Toulouse Purpan, Institut National de la Recherche Agronomique (INRA), Centre Hospitalier Universitaire de Nice (CHU Nice), Service Maladies infectieuses et tropicales [CHU Toulouse], Pôle Inflammation, infection, immunologie et loco-moteur [CHU Toulouse] (Pôle I3LM Toulouse), Centre Hospitalier Universitaire de Toulouse (CHU Toulouse)-Centre Hospitalier Universitaire de Toulouse (CHU Toulouse), Centre de Physiopathologie Toulouse Purpan (CPTP), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Centre de Recherches en Cancérologie de Toulouse (CRCT), Université de Toulouse (UT)-Université de Toulouse (UT)-Centre Hospitalier Universitaire de Toulouse (CHU Toulouse)-Institut National de la Santé et de la Recherche Médicale (INSERM), Institut de Recherche pour le Développement (IRD)-Institut de Chimie de Toulouse (ICT), Université de Toulouse (UT)-Université de Toulouse (UT)-Institut de Chimie du CNRS (INC)-Centre National de la Recherche Scientifique (CNRS)-Institut National Polytechnique (Toulouse) (Toulouse INP), Université de Toulouse (UT)-Institut de Recherche pour le Développement (IRD)-Université Toulouse III - Paul Sabatier (UT3), Université de Toulouse (UT), Université de Toulouse (UT)-Université de Toulouse (UT)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), CHU Toulouse [Toulouse]-Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Institut National de la Santé et de la Recherche Médicale (INSERM), Institut National Polytechnique (Toulouse) (Toulouse INP), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Centre National de la Recherche Scientifique (CNRS)-Institut de Recherche pour le Développement (IRD)-Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Institut de Chimie du CNRS (INC)-Institut National Polytechnique (Toulouse) (Toulouse INP), Université Fédérale Toulouse Midi-Pyrénées-Institut de Chimie du CNRS (INC), Service de Parasitologie et Mycologie, CHU Toulouse [Toulouse]-Institut Fédératif de Biologie (IFB) - Hôpital Purpan, Hôpital Purpan [Toulouse], CHU Toulouse [Toulouse]-CHU Toulouse [Toulouse]-Hôpital Purpan [Toulouse], CHU Toulouse [Toulouse], Service des maladies infectieuses et tropicales [Toulouse], Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-CHU Toulouse [Toulouse]-Hôpital Purpan [Toulouse], Centre National de la Recherche Scientifique (CNRS)-Université Toulouse III - Paul Sabatier (UT3)

المصدر: Medicine
Medicine, 2016, 95 (29), pp.e3932. ⟨10.1097/MD.0000000000003932⟩
Medicine, Lippincott, Williams & Wilkins, 2016, 95 (29), pp.e3932. ⟨10.1097/MD.0000000000003932⟩

مصطلحات موضوعية: 0301 basic medicine, Adult, Lymphadenopathy / parasitology, Male, Pathology, medicine.medical_specialty, diagnosis, Biopsy, [SDV]Life Sciences [q-bio], Biopsy, Fine-Needle, 030231 tropical medicine, 030106 microbiology, Diagnosis Differential, Antiprotozoal Agents, Leishmania donovani, Polymerase Chain Reaction, Lymphoid hyperplasia, Diagnosis, Differential, Amphotericin B / therapeutic use, 03 medical and health sciences, 0302 clinical medicine, Cervical lymphadenopathy, lymphadenopathy, medicine, Antiprotozoal Agents / therapeutic use, Humans, Clinical Case Report, Leishmania infantum, Leishmaniasis, biology, business.industry, General Medicine, medicine.disease, biology.organism_classification, amphotericin B, 3. Good health, [SDV] Life Sciences [q-bio], Visceral leishmaniasis, Fine-Needle, Leishmaniasis, Visceral, medicine.symptom, Differential diagnosis, Visceral / diagnosis, business, Epithelioid cell, Research Article

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a18af299ddd4e4d2e91ea41fee569b16
https://ut3-toulouseinp.hal.science/hal-03178303

المؤلفون: Massimo Attanasio, Antonino Giarratano, Andrea Cortegiani, Vincenzo Russotto, Santi Maurizio Raineri, Alessandro R Naro, Alessandra Maggiore

المساهمون: Cortegiani, A, Russotto, V, Maggiore, A, Attanasio, M, Naro, A, Raineri, S, Giarratano, A, Cortegiani, A., Russotto, V., Maggiore, A., Attanasio, M., Naro, A., Raineri, S., Giarratano, A.

المصدر: The Cochrane Library
Europe PubMed Central

مصطلحات موضوعية: Adult, medicine.medical_specialty, Antifungal drug, Mycose, intensive care medicine, law.invention, 03 medical and health sciences, Immunocompromised Host, critically ill patient, 0302 clinical medicine, Randomized controlled trial, law, Internal medicine, Amphotericin B, medicine, Humans, Antifungal Agent, Pharmacology (medical), 030212 general & internal medicine, MED/41 - ANESTESIOLOGIA, Intensive care medicine, Fluconazole, Fluconazole [therapeutic use], Randomized Controlled Trials as Topic, business.industry, fungal infection, Micafungin, 030208 emergency & critical care medicine, Publication bias, Mycoses [mortality, Clinical trial, Critical Illness [mortality], Amphotericin B [therapeutic use], Antifungal Agents [therapeutic use], prevention & control], Relative risk, Meta-analysis, Anidulafungin, Critical Illne, business, medicine.drug, Human

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c47be48f21a3243f3a98d3f970baf659
http://hdl.handle.net/10281/261637